Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-10

AUTHORS

C. Kahl, A. Florschütz, G. Müller, K. Jentsch-Ullrich, M. Arland, S. Leuner, A. Franke, H.-G. Höffkes

ABSTRACT

The detection of dysplastic features of hematopoiesis in de novo acute myeloid leukemia (AML) by light microscopy is defined as AML with trilineage myelodysplasia (AML/TLMD). The prognostic relevance of these dysplastic features for patients with de novo AML remains unclear. In order to evaluate the role of dysplasia in de novo AML, bone marrow aspirates from 69 patients were analyzed prospectively and investigated separately for erythropoiesis, granulopoiesis and megakaryopoiesis by three independent investigators. The overall complete remission (CR) rate was 48.8% and partial remission (PR) or nonresponders constituted 52.2% of the patients investigated. The median overall survival time was 5 months with a disease-free interval of 3.5 months for all patients. Dysgranulopoiesis (DysG) was observed in 30.4%, dysmegakaryopoiesis (DysM) in 50.7%, and dyserythropoiesis (DysE) in 43.5%. Of all patients, 26.0% showed trilineage dysplastic features and were thus classified as AML/TLMD. A significantly worse prognosis (Kaplan-Meyer plot, Student's t-test) was calculated for those patients with detection of only DysG (p = 0.002), DysM (p = 0.02), DysE (p = 0.04) as compared with patients without any dysplastic signs. An unfavorable karyotype was correlated with patients showing DysG (P = 0.02) and DysM (P = 0.04). For these patients with an unfavorable karyotype, the occurrence of any dysplastic features had no additional prognostic impact. Dysplastic features (DysG, DysM, DysE) seem to be an important prognostic factor in de novo AML correlating with short overall survival. DysG and DysM correlated well with the appearance of unfavorable chromosomal abnormalities. It may be reasonable to assume that patients with dysplastic features should be considered for more aggressive treatment schedules at the time of diagnosis. More... »

PAGES

91-94

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002770050320

DOI

http://dx.doi.org/10.1007/s002770050320

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040175409

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9368477


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoiesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Karyotyping", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kahl", 
        "givenName": "C.", 
        "id": "sg:person.01163662247.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163662247.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Florsch\u00fctz", 
        "givenName": "A.", 
        "id": "sg:person.013275267657.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013275267657.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "M\u00fcller", 
        "givenName": "G.", 
        "id": "sg:person.0771034331.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771034331.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jentsch-Ullrich", 
        "givenName": "K.", 
        "id": "sg:person.01064115756.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064115756.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arland", 
        "givenName": "M.", 
        "id": "sg:person.01204617764.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204617764.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leuner", 
        "givenName": "S.", 
        "id": "sg:person.01335737731.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335737731.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Franke", 
        "givenName": "A.", 
        "id": "sg:person.0620307426.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620307426.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Otto-von-Guericke University Magdeburg", 
          "id": "https://www.grid.ac/institutes/grid.5807.a", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00f6ffkes", 
        "givenName": "H.-G.", 
        "id": "sg:person.016451722644.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016451722644.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1987.tb01325.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004932480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1987.tb01328.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009610155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19800415)45:8<2017::aid-cncr2820450806>3.0.co;2-c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021077623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1989.tb04253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022340097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2257.1985.tb00007.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036620788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0145-2126(89)90142-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051654832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-78350-0_106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053219173", 
          "https://doi.org/10.1007/978-3-642-78350-0_106"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-10", 
    "datePublishedReg": "1997-10-01", 
    "description": "The detection of dysplastic features of hematopoiesis in de novo acute myeloid leukemia (AML) by light microscopy is defined as AML with trilineage myelodysplasia (AML/TLMD). The prognostic relevance of these dysplastic features for patients with de novo AML remains unclear. In order to evaluate the role of dysplasia in de novo AML, bone marrow aspirates from 69 patients were analyzed prospectively and investigated separately for erythropoiesis, granulopoiesis and megakaryopoiesis by three independent investigators. The overall complete remission (CR) rate was 48.8% and partial remission (PR) or nonresponders constituted 52.2% of the patients investigated. The median overall survival time was 5 months with a disease-free interval of 3.5 months for all patients. Dysgranulopoiesis (DysG) was observed in 30.4%, dysmegakaryopoiesis (DysM) in 50.7%, and dyserythropoiesis (DysE) in 43.5%. Of all patients, 26.0% showed trilineage dysplastic features and were thus classified as AML/TLMD. A significantly worse prognosis (Kaplan-Meyer plot, Student's t-test) was calculated for those patients with detection of only DysG (p = 0.002), DysM (p = 0.02), DysE (p = 0.04) as compared with patients without any dysplastic signs. An unfavorable karyotype was correlated with patients showing DysG (P = 0.02) and DysM (P = 0.04). For these patients with an unfavorable karyotype, the occurrence of any dysplastic features had no additional prognostic impact. Dysplastic features (DysG, DysM, DysE) seem to be an important prognostic factor in de novo AML correlating with short overall survival. DysG and DysM correlated well with the appearance of unfavorable chromosomal abnormalities. It may be reasonable to assume that patients with dysplastic features should be considered for more aggressive treatment schedules at the time of diagnosis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002770050320", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "75"
      }
    ], 
    "name": "Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia", 
    "pagination": "91-94", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bf61c573b879e1c2d1faef68d45adb918d5c4ce5d4217d3f55b13fcb6ea0ca05"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9368477"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002770050320"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040175409"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002770050320", 
      "https://app.dimensions.ai/details/publication/pub.1040175409"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000482.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s002770050320"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002770050320'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002770050320'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002770050320'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002770050320'


 

This table displays all metadata directly associated to this object as RDF triples.

200 TRIPLES      21 PREDICATES      51 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002770050320 schema:about N15453cb132234ba29866911a84846363
2 N16631aec4e55414cae1ff4984f1db7b2
3 N1d286e654c7f4340ad623ecc8fdfac74
4 N42bd86dcedf04b15b1e7ccd39ea59821
5 N4d90c43a682d44a5a0a397012c32c724
6 N579dbb8e0c9642968086bf3924113c9d
7 N6e44a35647ee4af89117d8e4daffc2ba
8 Nafeab8e4f45c44989caab5f341273e23
9 Nbb9632d1ea774de6a7c2ce843522db8f
10 Nbff123fcdcc84c138eeb63872a4180ca
11 Nda619a60e2994b2496d8de5782c69c59
12 Neba1a9cb5b334d76b2504e323ba1f5de
13 Neef20032675447f1935bb582bdc91e02
14 Nf5ecd49fb719400c8dbdd349c4c4324a
15 Nffe58ac34aa64228a853298f164dc430
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N42811364399842b886e8b5ecbc00b3da
19 schema:citation sg:pub.10.1007/978-3-642-78350-0_106
20 https://doi.org/10.1002/1097-0142(19800415)45:8<2017::aid-cncr2820450806>3.0.co;2-c
21 https://doi.org/10.1016/0145-2126(89)90142-2
22 https://doi.org/10.1111/j.1365-2141.1987.tb01325.x
23 https://doi.org/10.1111/j.1365-2141.1987.tb01328.x
24 https://doi.org/10.1111/j.1365-2141.1989.tb04253.x
25 https://doi.org/10.1111/j.1365-2257.1985.tb00007.x
26 schema:datePublished 1997-10
27 schema:datePublishedReg 1997-10-01
28 schema:description The detection of dysplastic features of hematopoiesis in de novo acute myeloid leukemia (AML) by light microscopy is defined as AML with trilineage myelodysplasia (AML/TLMD). The prognostic relevance of these dysplastic features for patients with de novo AML remains unclear. In order to evaluate the role of dysplasia in de novo AML, bone marrow aspirates from 69 patients were analyzed prospectively and investigated separately for erythropoiesis, granulopoiesis and megakaryopoiesis by three independent investigators. The overall complete remission (CR) rate was 48.8% and partial remission (PR) or nonresponders constituted 52.2% of the patients investigated. The median overall survival time was 5 months with a disease-free interval of 3.5 months for all patients. Dysgranulopoiesis (DysG) was observed in 30.4%, dysmegakaryopoiesis (DysM) in 50.7%, and dyserythropoiesis (DysE) in 43.5%. Of all patients, 26.0% showed trilineage dysplastic features and were thus classified as AML/TLMD. A significantly worse prognosis (Kaplan-Meyer plot, Student's t-test) was calculated for those patients with detection of only DysG (p = 0.002), DysM (p = 0.02), DysE (p = 0.04) as compared with patients without any dysplastic signs. An unfavorable karyotype was correlated with patients showing DysG (P = 0.02) and DysM (P = 0.04). For these patients with an unfavorable karyotype, the occurrence of any dysplastic features had no additional prognostic impact. Dysplastic features (DysG, DysM, DysE) seem to be an important prognostic factor in de novo AML correlating with short overall survival. DysG and DysM correlated well with the appearance of unfavorable chromosomal abnormalities. It may be reasonable to assume that patients with dysplastic features should be considered for more aggressive treatment schedules at the time of diagnosis.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf N0036b9d0fbfe477f8216babadc090951
33 N8a1825c382d8434caad3d2a40161b76c
34 sg:journal.1018247
35 schema:name Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia
36 schema:pagination 91-94
37 schema:productId N065f389ce1424b5093489adc1794a6f9
38 N3a93544c53ee401d9fb245b29757eab2
39 N46e4ab63df134bde9c37fc904b72086e
40 N623a18323c394b86bf9269a2a26a9261
41 N868a86a53ab94348a1190b25cff253fc
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040175409
43 https://doi.org/10.1007/s002770050320
44 schema:sdDatePublished 2019-04-10T22:24
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher N3278b1ccc27148f89a7734b3404b50f7
47 schema:url http://link.springer.com/10.1007/s002770050320
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N0036b9d0fbfe477f8216babadc090951 schema:issueNumber 3
52 rdf:type schema:PublicationIssue
53 N065f389ce1424b5093489adc1794a6f9 schema:name pubmed_id
54 schema:value 9368477
55 rdf:type schema:PropertyValue
56 N15453cb132234ba29866911a84846363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Male
58 rdf:type schema:DefinedTerm
59 N16631aec4e55414cae1ff4984f1db7b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Aged
61 rdf:type schema:DefinedTerm
62 N1d286e654c7f4340ad623ecc8fdfac74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Survival Analysis
64 rdf:type schema:DefinedTerm
65 N3278b1ccc27148f89a7734b3404b50f7 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N32f309a690d044038cc032ac46ac1544 rdf:first sg:person.013275267657.19
68 rdf:rest N3c6c66e65a4b43b2b2e29f1f3687ef60
69 N3a93544c53ee401d9fb245b29757eab2 schema:name readcube_id
70 schema:value bf61c573b879e1c2d1faef68d45adb918d5c4ce5d4217d3f55b13fcb6ea0ca05
71 rdf:type schema:PropertyValue
72 N3c6c66e65a4b43b2b2e29f1f3687ef60 rdf:first sg:person.0771034331.54
73 rdf:rest Nf5b8ad90e98a450091adc03315a1c0e1
74 N42811364399842b886e8b5ecbc00b3da rdf:first sg:person.01163662247.08
75 rdf:rest N32f309a690d044038cc032ac46ac1544
76 N42bd86dcedf04b15b1e7ccd39ea59821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Aged, 80 and over
78 rdf:type schema:DefinedTerm
79 N46e4ab63df134bde9c37fc904b72086e schema:name doi
80 schema:value 10.1007/s002770050320
81 rdf:type schema:PropertyValue
82 N4c85b914510c40229bba3f7892fda079 rdf:first sg:person.0620307426.77
83 rdf:rest Nc9d88de980064d5abdbdaac32a2e820b
84 N4d90c43a682d44a5a0a397012c32c724 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Prognosis
86 rdf:type schema:DefinedTerm
87 N579dbb8e0c9642968086bf3924113c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Leukemia, Myeloid, Acute
89 rdf:type schema:DefinedTerm
90 N623a18323c394b86bf9269a2a26a9261 schema:name nlm_unique_id
91 schema:value 9107334
92 rdf:type schema:PropertyValue
93 N6e44a35647ee4af89117d8e4daffc2ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Adult
95 rdf:type schema:DefinedTerm
96 N868a86a53ab94348a1190b25cff253fc schema:name dimensions_id
97 schema:value pub.1040175409
98 rdf:type schema:PropertyValue
99 N8a1825c382d8434caad3d2a40161b76c schema:volumeNumber 75
100 rdf:type schema:PublicationVolume
101 Nad32c7a3db2c43b3b5f44e5ddc950282 rdf:first sg:person.01335737731.35
102 rdf:rest N4c85b914510c40229bba3f7892fda079
103 Nafeab8e4f45c44989caab5f341273e23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Female
105 rdf:type schema:DefinedTerm
106 Nbb9632d1ea774de6a7c2ce843522db8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Hematopoiesis
108 rdf:type schema:DefinedTerm
109 Nbff123fcdcc84c138eeb63872a4180ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Myelodysplastic Syndromes
111 rdf:type schema:DefinedTerm
112 Nc9d88de980064d5abdbdaac32a2e820b rdf:first sg:person.016451722644.29
113 rdf:rest rdf:nil
114 Nda619a60e2994b2496d8de5782c69c59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Karyotyping
116 rdf:type schema:DefinedTerm
117 Neb2f2b817e31468cac71b3ad228da712 rdf:first sg:person.01204617764.45
118 rdf:rest Nad32c7a3db2c43b3b5f44e5ddc950282
119 Neba1a9cb5b334d76b2504e323ba1f5de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adolescent
121 rdf:type schema:DefinedTerm
122 Neef20032675447f1935bb582bdc91e02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Prospective Studies
124 rdf:type schema:DefinedTerm
125 Nf5b8ad90e98a450091adc03315a1c0e1 rdf:first sg:person.01064115756.35
126 rdf:rest Neb2f2b817e31468cac71b3ad228da712
127 Nf5ecd49fb719400c8dbdd349c4c4324a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Middle Aged
129 rdf:type schema:DefinedTerm
130 Nffe58ac34aa64228a853298f164dc430 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
134 schema:name Medical and Health Sciences
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
137 schema:name Oncology and Carcinogenesis
138 rdf:type schema:DefinedTerm
139 sg:journal.1018247 schema:issn 1269-3286
140 1279-8509
141 schema:name Annals of Hematology
142 rdf:type schema:Periodical
143 sg:person.01064115756.35 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
144 schema:familyName Jentsch-Ullrich
145 schema:givenName K.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064115756.35
147 rdf:type schema:Person
148 sg:person.01163662247.08 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
149 schema:familyName Kahl
150 schema:givenName C.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163662247.08
152 rdf:type schema:Person
153 sg:person.01204617764.45 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
154 schema:familyName Arland
155 schema:givenName M.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204617764.45
157 rdf:type schema:Person
158 sg:person.013275267657.19 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
159 schema:familyName Florschütz
160 schema:givenName A.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013275267657.19
162 rdf:type schema:Person
163 sg:person.01335737731.35 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
164 schema:familyName Leuner
165 schema:givenName S.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335737731.35
167 rdf:type schema:Person
168 sg:person.016451722644.29 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
169 schema:familyName Höffkes
170 schema:givenName H.-G.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016451722644.29
172 rdf:type schema:Person
173 sg:person.0620307426.77 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
174 schema:familyName Franke
175 schema:givenName A.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620307426.77
177 rdf:type schema:Person
178 sg:person.0771034331.54 schema:affiliation https://www.grid.ac/institutes/grid.5807.a
179 schema:familyName Müller
180 schema:givenName G.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771034331.54
182 rdf:type schema:Person
183 sg:pub.10.1007/978-3-642-78350-0_106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053219173
184 https://doi.org/10.1007/978-3-642-78350-0_106
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1002/1097-0142(19800415)45:8<2017::aid-cncr2820450806>3.0.co;2-c schema:sameAs https://app.dimensions.ai/details/publication/pub.1021077623
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/0145-2126(89)90142-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051654832
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1365-2141.1987.tb01325.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004932480
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1111/j.1365-2141.1987.tb01328.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009610155
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1111/j.1365-2141.1989.tb04253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1022340097
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1111/j.1365-2257.1985.tb00007.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036620788
197 rdf:type schema:CreativeWork
198 https://www.grid.ac/institutes/grid.5807.a schema:alternateName Otto-von-Guericke University Magdeburg
199 schema:name Division of Hematology/Oncology, Department of Medicine, Otto-von-Guericke University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany, DE
200 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...